alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
PGI 205.2 -SYNOPSES OF PROPOSED CONTRACT ACTIONS    **Parent topic:** PGI Part 205 - PUBLICIZING CONTRACT ACTIONSPGI 205.205 Special situations.       (h) Notice regarding timely definitization of equitable adjustments for change orders under construction contracts. To obtain definitization data for requests for equitable adjustment to include in solicitations for construction contracts, access the PALT/Protest/REA Tracker module in the Procurement Integrated Enterprise Environment (PIEE) website at https://piee.eb.mil. Search the PALT/Protest/REA Tracker for the applicable military department or defense agency data and—          (i) If data exists, download the table and include it as an attachment to the solicitation notice in the Governmentwide point of entry (GPE); or          (ii) If no data exists, then include the following statement in the Description section of the solicitation notice: “No data is available regarding the timely definitization of equitable adjustments for change orders under construction contracts.” (See PGI 236.211(b)(2) for reporting data on definitization of equitable adjustments.)          (iii) Include a description of military department or defense agency policies or procedures, in addition to that outlined in FAR 43.204, that apply to definitization of equitable adjustments for change orders under construction contracts. This description may be provided in a notice by including an address of an agency-specific, publicly available website containing this information.          (iv) If the military department or defense agency does not have agency-specific procedures, include the following statement: “There are no agency-specific policies or procedures that apply to the definitization of equitable adjustments for change orders under construction contracts.”PGI 205.207 Preparation and transmittal of synopses.       (a)(i) *Notice numbering*.          (1) For a particular procurement, when submitting notices at different stages of the acquisition (i.e., sources sought notice, pre-solicitation notice, award notice), ensure the solicitation number is entered exactly the same way in order to allow all to be retrieved when a search is performed.          (2) Use only alpha-numeric characters in the solicitation and award number data elements in the GPE. Do not include hyphens, slashes, or other special characters.          (d) *Special notices for small business events*. When advertising an event for small businesses, post a 'special notice' notice type and ensure the "title" data field begins with "Small Business Event". This will enable the public to easily search the GPE using the small business event calendar on the website.
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsBOREAS TE-1 Soils Data Over The SSA Tower Sites in Raster FormatThe BOREAS TE-1 team collected various data to characterize the soil-plant systems in the BOREAS SSA. This data set was gridded from vector layers of soil maps that were received from Dr. Darwin Anderson (TE-1), who did the original soil mapping in the field during 1994. The vector layers were gridded into raster files that cover approximately 1 square kilometer over each of the tower sites in the SSA. The data files are available on a CD-ROM (see document number 20010000884), or from the Oak Ridge National Laboratory (ORNL) Distributed Active Archive Center (DAAC).Document ID20010003947Acquisition SourceGoddard Space Flight CenterDocument TypeTechnical Memorandum (TM)AuthorsHall, Forrest G.*(NASA Goddard Space Flight Center Greenbelt, MD United States)*Anderson, Darwin*(Saskatchewan Univ. Saskatoon, Saskatchewan Canada)*Knapp, David E.*(Raytheon Information Technology and Scientific Services Greenbelt, MD United States)*Date AcquiredSeptember 7, 2013Publication DateOctober 1, 2000Subject CategoryEarth Resources And Remote SensingReport/Patent NumberRept-2000-03136-0/VOL125NASA/TM-2000-209891/VOL125NAS 1.15:209891/VOL125Funding Number(s)PROJECT: RTOP 462-33-01Distribution LimitsPublicCopyrightWork of the US Gov. Public Use Permitted.Available DownloadsNameType20010003947.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
Exhibit
        32.2
 
 CERTIFICATION
        OF PERIODIC FINANCIAL REPORT PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
        ACT
        OF 2002, 18 U.S.C. SECTION 1350
 
 
 In
        connection with the quarterly report of Simclar, Inc. (the “Company”) on Form
        10-Q for the period ended March 31, 2006, as filed with the Securities and
        Exchange Commission on the date hereof (the “Report”), I, Steven T. Ker, Chief
        Financial Officer and Secretary of the Company, hereby certify as of the
        date
        hereof, solely for purpose of Title 18, Chapter 63, Section 1350 of the United
        States Code, that to the best of my knowledge:
 
 (1)  The
        Report fully complies with the requirements of section 13(a) or 15(d) of
        the
        Securities Exchange Act of 1934; and
 
 (2)  The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and result of operations of the Company.
 
 This
        Certification has not been, and shall not be deemed, “filed” with the Securities
        and Exchange Commission.
  Date: May
                15, 2006
              By:
              /s/ Marshall
                W. Griffin, Jr.Marshall
                  W. Griffin, Jr., Chief Financial Officer and Secretary
                Simclar,
                  Inc.
1042.1500 [Reserved]

Parent topic: PART 1042 - CONTRACT ADMINISTRATION AND AUDIT SERVICES
1429.303 Application of State and local taxes to Government contractors and subcontractors.       Contractors to be treated as agents of the Government for the purposes set forth in FAR 29.303(a) shall require the written review and approval of the AS/PMB. The HCA shall submit requests for approval through SOL, to the Director, PAM, for further action.    **Parent topic:** Subpart 1429.3 - State and Local Taxes
436.670 Firms ineligible for award -

construction.

The contracting officer shall insert the clause at 452.236-80, Firms Ineligible For Award -

Construction, in the contract for architect-engineering services except as provided in FAR 36.209

and AGAR 436.209.

Parent topic: Subpart 436.6 - Architect-Engineer Service
#### Robin Lurie, Respondent, v Brooklyn Union Gas Company, Also Known as Keyspan Energy Delivery, Inc., Appel*539lant, and Consolidated Edison Company of New York, Inc., Respondent.

[813 NYS2d 670]

In an action to recover damages for personal injuries, the defendant Brooklyn Union Gas Company, also known as Keyspan Energy Delivery, Inc., appeals from an order of the Supreme Court, Kings County (Ruchelsman, J.), dated January 24, 2005, which denied its motion for summary judgment dismissing the complaint and all cross claims insofar as asserted against it.

Ordered that the order is affirmed, without costs or disbursements.

Contrary to the appellant’s contentions, it did not establish a prima facie case for summary judgment dismissing the complaint and all cross claims insofar as asserted against it. The appellant failed to submit sufficient evidence in admissible form, demonstrating the absence of a triable issue of fact regarding whether it created the alleged hazard *(see Rengifo v City of New York,*7 AD3d 773 [2004]). Goldstein, J.P., Mastro, Rivera and Lunn, JJ., concur.
<TABLE> <S> <C>


<ARTICLE> 5 

       

<S>                                               <C>
<PERIOD-TYPE>                                     3-MOS
<FISCAL-YEAR-END>                                 DEC-31-1999
<PERIOD-START>                                    JAN-01-1999
<PERIOD-END>                                      MAR-31-1999
<CASH>                                             1,171,843
<SECURITIES>                                               0
<RECEIVABLES>                                      5,875,603
<ALLOWANCES>                                               0
<INVENTORY>                                        7,627,703
<CURRENT-ASSETS>                                  15,338,711
<PP&E>                                             9,238,660
<DEPRECIATION>                                     4,085,151
<TOTAL-ASSETS>                                    23,270,535
<CURRENT-LIABILITIES>                              6,380,024
<BONDS>                                            4,272,788
<PREFERRED-MANDATORY>                                      0
<PREFERRED>                                                0
<COMMON>                                              52,501
<OTHER-SE>                                         9,189,643
<TOTAL-LIABILITY-AND-EQUITY>                      23,270,535
<SALES>                                            9,834,994
<TOTAL-REVENUES>                                   9,857,115
<CGS>                                              8,818,948
<TOTAL-COSTS>                                      8,818,948
<OTHER-EXPENSES>                                     995,059
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                   165,323
<INCOME-PRETAX>                                     (122,215)
<INCOME-TAX>                                          26,913
<INCOME-CONTINUING>                                 (149,128)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                        (149,128)
<EPS-PRIMARY>                                           (.03)
<EPS-DILUTED>                                           (.03)
<FN>
<F1>Accounts receivable are net of allowance of $47,000 at March 31, 
    1999.
<F2>Inventories are net of reserve of $559,000 at March 31, 1999.
<FN>
        

</TABLE>
Editorial Note on Part 35
Editorial Note: Nomenclature changes to part 35 appear at 79 FR 75739, Dec. 19, 2014.

§ 35.300 Use of unsealed byproduct material for which a written directive is required. A licensee may use any unsealed byproduct material identified in § 35.390(b)(1)(ii)(G) prepared for medical use and for which a written directive is required that is— ( a ) Obtained from: ( 1 ) A manufacturer or preparer licensed under § 32.72 of this chapter or equivalent Agreement State requirements; or
( 2 ) A PET radioactive drug producer licensed under § 30.32(j) of this chapter or equivalent Agreement State requirements; or
( b ) Excluding production of PET radionuclides, prepared by: ( 1 ) An authorized nuclear pharmacist;
( 2 ) A physician who is an authorized user and who meets the requirements specified in §§ 35.290, 35.390, or
( 3 ) An individual under the supervision, as specified in § 35.27, of the authorized nuclear pharmacist in paragraph (b)(1) of this section or the physician who is an authorized user in paragraph (b)(2) of this section; or
( c ) Obtained from and prepared by an NRC or Agreement State licensee for use in research in accordance with an Investigational New Drug (IND) protocol accepted by FDA; or
( d ) Prepared by the licensee for use in research in accordance with an Investigational New Drug (IND) protocol accepted by FDA.
[67 FR 20370, Apr. 24, 2002, as amended at 68 FR 19324, Apr. 21, 2003; 71 FR 15009, Mar. 27, 2006; 72 FR 55932, Oct. 1, 2007; 83 FR 33107, July 16, 2018]
Searched for **http://www.ssa.gov/international/Agreement_Pamphlets/italy.html**

 

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

*Note:* This calendar view maps the number of captures of **http://www.ssa.gov/international/Agreement_Pamphlets/italy.html**, *not* how many times the site was actually updated.

Look Up URL in general Internet Archive web collection.
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsBOREAS TE-9 NSA Canopy BiochemistryThe BOREAS TE-9 team collected several data sets related to chemical and photosynthetic properties of leaves. This data set contains canopy biochemistry data collected in 1994 in the NSA at the YJP, OJR, OBS, UBS, and OA sites, including biochemistry lignin, nitrogen, cellulose, starch, and fiber concentrations. These data were collected to study the spatial and temporal changes in the canopy biochemistry of boreal forest cover types and how a high-resolution radiative transfer model in the mid-infrared could be applied in an effort to obtain better estimates of canopy biochemical properties using remote sensing. The data are available in tabular ASCII files. The data files are available on a CD-ROM (see document number 20010000884), or from the Oak Ridge National Laboratory (ORNL) Distributed Active Archive Center (DAAC).Document ID20010004609Acquisition SourceGoddard Space Flight CenterDocument TypeTechnical Memorandum (TM)AuthorsHall, Forrest G.*(NASA Goddard Space Flight Center Greenbelt, MD United States)*Curd, Shelaine*(Raytheon Information Technology and Scientific Services Greenbelt, MD United States)*Margolis, Hank*(Laval Univ. Sainte-Foye, Quebec Canada)*Charest, Martin*(Laval Univ. Sainte-Foye, Quebec Canada)*Sy, Mikailou*(Laval Univ. Sainte-Foye, Quebec Canada)*Date AcquiredSeptember 7, 2013Publication DateOctober 1, 2000Subject CategoryEarth Resources And Remote SensingReport/Patent NumberRept-2000-03136-0/VOL154NAS 1.15:209891/VOL154NASA/TM-2000-209891/VOL154Funding Number(s)PROJECT: RTOP 462-33-01Distribution LimitsPublicCopyrightWork of the US Gov. Public Use Permitted.Available DownloadsNameType20010004609.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
§ 33.8 Information collection requirements: OMB approval. ( a ) The Nuclear Regulatory Commission has submitted the information collection requirements contained in this part to the Office of Management and Budget (OMB) for approval as required by the Paperwork Reduction Act (44 U.S.C. 3501 *et seq.*). The NRC may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has approved the information collection requirements contained in this part under control number 3150-0015.
( b ) The approved information collection requirements contained in this part appear in §§ 33.12, 33.13, 33.14 and 33.15.
( c ) This part contains information collection requirements in addition to those approved under the control number specified in paragraph (a) of this section. These information collection requirements and the control numbers under which they are approved are as follows: ( 1 ) In § 33.12, NRC Form 313 is approved under control number 3150-0120.
( 2 ) [Reserved]
[49 FR 19625, May 9, 1984, as amended at 62 FR 52186, Oct. 6, 1997; 67 FR 67099, Nov. 4, 2002]
Editorial Note on Part 35
Editorial Note: Nomenclature changes to part 35 appear at 79 FR 75739, Dec. 19, 2014.

§ 35.63 Determination of dosages of unsealed byproduct material for medical use. ( a ) A licensee shall determine and record the activity of each dosage before medical use.
( b ) For a unit dosage, this determination must be made by— ( 1 ) Direct measurement of radioactivity; or
( 2 ) A decay correction, based on the activity or activity concentration determined by— ( i ) A manufacturer or preparer licensed under § 32.72 of this chapter or equivalent Agreement State requirements; or
( ii ) An NRC or Agreement State licensee for use in research in accordance with a Radioactive Drug Research Committee-approved protocol or an Investigational New Drug (IND) protocol accepted by FDA; or
( iii ) A PET radioactive drug producer licensed under § 30.32(j) of this chapter or equivalent Agreement State requirements.
( c ) For other than unit dosages, this determination must be made by— ( 1 ) Direct measurement of radioactivity;
( 2 ) Combination of measurement of radioactivity and mathematical calculations; or
( 3 ) Combination of volumetric measurements and mathematical calculations, based on the measurement made by: ( i ) A manufacturer or preparer licensed under § 32.72 of this chapter or equivalent Agreement State requirements; or
( ii ) A PET radioactive drug producer licensed under § 30.32(j) of this chapter or equivalent Agreement State requirements.
( d ) Unless otherwise directed by the authorized user, a licensee may not use a dosage if the dosage does not fall within the prescribed dosage range or if the dosage differs from the prescribed dosage by more than 20 percent.
( e ) A licensee shall retain a record of the dosage determination required by this section in accordance with § 35.2063.
[67 FR 20370, Apr. 24, 2002, as amended at 72 FR 55931, Oct. 1, 2007]
#### CZOSEK, Respondent, v. JAECKLE, Appellant.

(Supreme Court, Appellate Division, Fourth Department.

July 12, 1906.)

Action by Paul Czosek, etc., against Mary Jaeckle, etc.

No opinion. Judgment and order affirmed, with costs.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-END>                               DEC-31-1995
<CASH>                                          54,155
<SECURITIES>                                         0
<RECEIVABLES>                                  433,050
<ALLOWANCES>                                         0
<INVENTORY>                                  4,757,527
<CURRENT-ASSETS>                                     0
<PP&E>                                          20,509
<DEPRECIATION>                                  13,351
<TOTAL-ASSETS>                               5,285,227
<CURRENT-LIABILITIES>                                0
<BONDS>                                      1,558,643
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 5,285,227
<SALES>                                        140,000
<TOTAL-REVENUES>                               144,044
<CGS>                                          106,210
<TOTAL-COSTS>                                  106,210
<OTHER-EXPENSES>                               253,616
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,618
<INCOME-PRETAX>                              (231,400)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (231,400)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (231,400)
<EPS-PRIMARY>                                    (.05)
<EPS-DILUTED>                                        0
        

</TABLE>
1209.602 General.

(c) Contracting officers shall require offerors to disclose teaming arrangements as a part of any

offer. The teaming arrangement shall be evaluated as a part of overall prime contractor

responsibility, as well as under the technical and/or management approach evaluation factor where

applicable.

Parent topic: Subpart 1209.6—Contractor Team Arrangements
Defense Logistics Acquisition Directive

(DLAD)

Revised August 30, 2022 by the:

DEFENSE LOGISTICS ACQUISITION DIRECTIVE

TITLE 48 - Federal Acquisition Regulations System

Chapter 54

Parent topic: Volume 7 - Parts 1-53 and 201-299
IN THE DISTRICT COURT OF THE UNITED STATES FOR THE

MIDDLE DISTRICT OF ALABAMA, EASTERN DIVISION

OWEN J. ROGAL, D.D.S., )

P.C., )

)

Plaintiff, )

) CIVIL ACTION NO.

v. ) 3:06cv711-MHT

) 

SKILSTAF, INC., )

)

Defendant. )

ORDER

It is ORDERED that the motion for leave to reply

(Doc. No. 70) is granted.

DONE, this the 22nd day of August, 2007.

 /s/ Myron H. Thompson 

UNITED STATES DISTRICT JUDGE

Case 3:06-cv-00711-MHT-WC Document 72 Filed 08/22/2007 Page 1 of 1
**Exhibit 31.2**

 

**Citizens Financial Corp.**

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

 

I, Thomas K. Derbyshire, Vice President, Treasurer and Principal Financial Officer of Citizens Financial Corp., certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Citizens Financial Corp; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly presentin all material respects the financial condition, results in operations and cash flows of the registrant as of, and for, the periods presented in this report. 

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, includingits consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I havedisclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses inthe design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

(b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: August 10, 2005
Case 2:06-cv-00767-MEF-SRW Document 13 Filed 09/28/2006 Page 1 of 2
Case 2:06-cv-00767-MEF-SRW Document 13 Filed 09/28/2006 Page 2 of 2
Case 3:06-cr-00195-MEF-CSC Document 1 Filed 08/15/2006 Page 1 of 2
Case 3:06-cr-00195-MEF-CSC Document 1 Filed 08/15/2006 Page 2 of 2